WEBSITECHANGES

Website Changes

---

08/21/2022

Intratumoral oncolytic herpes virus G47? for residual or recurrent glioblastoma: a phase 2 trial

---

08/21/2022

Local musician fights cancer to get back to doing what he loves

---

08/16/2022

Phase I trial of adjuvant mature autologous dendritic cell/allogeneic tumor lysate vaccines in combination with temozolomide in newly diagnosed glioblastoma

---

08/16/2022

Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields

---

08/16/2022

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

---

08/15/2022

Cancer Commons and Musella Foundation For Brain Tumor Research Launch Pilot Study of Individualized Treatments for GBM

---

08/15/2022

Musella Foundation Awards Two More Brain Tumor Research Grants!

---

08/11/2022

Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

---

08/09/2022

National Walk To End Brain Tumors to be held Sept 24, 2022 in New Egypt, NJ

---

08/08/2022

Parents demand new brain cancer drug be made available in Australia

---

08/01/2022

Musella Foundation Copayment Assistance Program is now open to new and renewal patients!

---

08/01/2022

Introduction to ROON!

---

08/01/2022

Kazia Therapeutics : PROVIDES PROGRESS UPDATE ON GBM AGILE PIVOTAL STUDY

---

07/30/2022

Intratumoral oncolytic herpes virus G47? for residual or recurrent glioblastoma: a phase 2 trial

---

07/30/2022

Continuing maintenance temozolomide therapy beyond 12 cycles confers no clinical benefit over discontinuation at 12 cycles in patients with IDH1/2-wildtype glioblastoma

---

07/30/2022

Chemotherapy drug temozolomide analog shows promise in treating glioma

---

07/29/2022

Regorafenib in Pretreated Patients With Progressive CNS Grade 3 or 4 Gliomas

---

07/28/2022

ERC Granted FDA Fast Track Designation for Sitoiganap in Patients with Recurrent Glioblastoma

---

07/24/2022

Advanced MRI Measurements of Brain Tumors (video)

---

07/23/2022

An implantable ultrasound-powered device for the treatment of brain cancer using electromagnetic fields

---

07/23/2022

Genentech-led team uncovers how cancer cells resist T-cell attack in potential boon to immunotherapy

---

07/21/2022

CORRECTION on " NCCN Guidelines Recommend Optune as a Standard Treatment Option for Newly Diagnosed Glioblastoma "

---

07/20/2022

The mechanisms of action of Tumor Treating Fields

---

07/20/2022

A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma

---

07/20/2022

Musella Foundation Celebrates Glioblastoma Awareness Day by publishing new edition of the "Brain Tumor Guide For The Newly Diagnosed"!

---